[1]秦 帅,侯光辉,祁 冰,等.多种药物联合治疗白内障术后干眼症的临床效果观察[J].医学信息,2019,(04):142-144.[doi:10.3969/j.issn.1006-1959.2019.04.046]
 QIN Shuai,HOU Guang-hui,QI Bing,et al.Clinical Observation of Multiple Drugs Combined with Xerophthalmia after Cataract Surgery[J].Medical Information,2019,(04):142-144.[doi:10.3969/j.issn.1006-1959.2019.04.046]
点击复制

多种药物联合治疗白内障术后干眼症的临床效果观察()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2019年04期
页码:
142-144
栏目:
药物与临床
出版日期:
2019-02-15

文章信息/Info

Title:
Clinical Observation of Multiple Drugs Combined with Xerophthalmia after Cataract Surgery
文章编号:
1006-1959(2019)04-0142-03
作者:
秦 帅侯光辉祁 冰郭 锐
(珠海市人民医院眼科,广东 珠海 519000)
Author(s):
QIN ShuaiHOU Guang-huiQI BingGUO Rui
(Department of Ophthalmology,Zhuhai People's Hospital,Zhuhai 519000,Guangdong,China)
关键词:
白内障干眼症普拉洛芬贝复舒
Keywords:
CataractXerophthalmiaPranoprofenBefushu
分类号:
R779.6
DOI:
10.3969/j.issn.1006-1959.2019.04.046
文献标志码:
A
摘要:
目的 探讨多种药物联合治疗白内障术后干眼症的临床疗效。方法 选取2015年5月~2018年 9 月于我院行白内障手术术后干眼患者125例,随机分为A、B、C组三组,C组患者采用玻璃酸钠滴眼液治疗,A组在C组基础上加用贝复舒滴眼液治疗,B组在C组基础上加用普拉洛芬滴眼液治疗,比较各组患者治疗前后OSDI值、BUT、SIt值、FL的变化,比较各组患者治疗前后OSDI值、BUT、SIt值、FL的变化。结果 治疗后三组患者BUT,SIt值比较,差异有统计学意义(P<0.05);治疗后三组OSDI值,FL比较,差异无统计学意义(P>0.05);B组患者治疗的总有效率(95.24%)高于A组(93.02%)及C组(87.50%),差异有统计学意义(P<0.05)。结论 玻璃酸钠滴眼液联合普拉洛芬滴眼液、玻璃酸钠滴眼液联合贝复舒滴眼液及单纯使用玻璃酸钠滴眼液均可减轻白内障术后干眼症患者的症状,增加泪液分泌量,延长泪膜破裂时间,使角膜染色降低,但玻璃酸钠滴眼液联合普拉洛芬滴眼液的治疗方案更佳。
Abstract:
Objective To investigate the clinical efficacy of multiple drugs in the treatment of xerophthalmiaafter cataract surgery. Methods A total of 125 patients with xerophthalmia who underwent cataract surgery in our hospital from May 2015 to September 2018 were randomly divided into three groups: group A, group B and group C. Patients in group C were treated with sodium hyaluronate eye drops. Group A was treated with Beifushu eye drops on the basis of group C. Group B was treated with pranoprofen eye drops on the basis of group C.The changes of OSDI, BUT, SIt and FL before and after treatment were compared between the groups. Results After treatment, the BUT and SIt values of the three groups were significantly different (P<0.05). There were no significant differences in the OSDI values and FL between the three groups after treatment (P>0.05). The effective rate (95.24%) was higher than that of group A (93.02%) and group C (87.50%),the difference was statistically significant (P<0.05). Conclusion Sodium hyaluronate eye drops combined with pranoprofen eye drops, sodium hyaluronate eye drops combined with Beifushu eye drops and sodium hyaluronate eye drops alone can alleviate the symptoms of xerophthalmia patients after cataract surgery. Increase the amount of tear secretion, prolong the tear film rupture time, and reduce the cornea staining, but the treatment plan of sodium hyaluronate eye drops combined with pranoprofen eye drops is better.

参考文献/References:


[1]Nelson JD,Craig JP,Akpek EK,et al.TFOS DEWS Ⅱ introduction[J].OculSurf,2017,15(3):269-275.
[2]JuthaniVV,Clearfield E,Chuck RS.Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery[J].Cochrane Database Syst Rev,2017(7):CD010516.
[3]张正,李银花,丁亚丽,等.干眼症的发病机制及治疗现状[J].中华眼科医学杂志,2014,4(2):44-46.
[4]Schiffman RM,Christianson MD,Jacobsen G,et al.Reliability and validity of the ocular surface disease index[J].Archives of Ophthalmology,2000,118(5):615-621.
[5]Wolffsohn JS,Arita R,Chalmers R,et al.TFOS DEWS Ⅱ Diagnostic Methodology report[J].Ocul Surf,2017,15(3):539-574.
[6]冯淑杰.玻璃酸钠滴眼液联合贝复舒滴眼液改善干眼症患者临床症状的效果分析[J].临床合理用药杂志,2015,8(27):62-63.
[7]范云霞.浅析白内障超声乳化术后干眼症药物治疗的临床效果[J].中国保健营养,2017,26(34):93.
[8]姚小琪.玻璃酸钠滴眼液与双氯芬酸钠滴眼液治疗干眼症临床观察[J].临床医学研究与实践,2016,1(26):37-38.
[9]赵仲平,郭翠玲,邵鸿展,等.普拉洛芬联合玻璃酸钠治疗中重度干眼症的临床观察[J].中国药房,2016,27(35):4956-4959.
[10]黎锦萍,周沛辉,陈硕,等.玻璃酸钠滴眼液与贝复舒滴眼液联合治疗干眼症效果[J].牡丹江医学院学报,2017,38(1):66-67.
[11]张凯.聚乙烯醇滴眼液联合贝复舒滴眼液治疗干眼症的疗效观察[J].吉林医学,2015,36(4):621-623.
[12]陈景尧,谢立信,刘祖国,等.普拉洛芬治疗轻中度干眼的多中心随机对照临床试验[J].中华实验眼科杂志,2015,33(9):834-839.
[13]靳素娟.玻璃酸钠联合rhEGF滴眼治疗白内障术后干眼症泪膜的临床效果[J].临床医学,2018,38(3):114-115.
[14]Messmer EM.The pathophysiology,diagnosis,and treatment of dry eye disease[J].DtschArztebl Int,2015,112(5):71-81.
[15]赵光明,赵平,倪宝玲,等.人工泪液联合普拉洛芬治疗青光眼术后干眼症的疗效[J].国际眼科杂志,2015,15(2):370-372.
[16]王刚.普拉洛芬滴眼液治疗干眼症眼表炎症的临床效果[J].临床合理用药杂志,2017,10(8):75-76.
[17]黄鹤龄,李平,莫元外.炎性细胞因子在蒸发过强型干眼的发病机制中的作用[J].国际眼科杂志,2015,15(12):2177-2179.
[18]秦华.普拉洛芬滴眼液在白内障患者术后炎症中的应用效果[J].中国当代医药,2015,22(15):71-73.
[19]王艳丽,冯梅,徐志蓉,等.普拉洛芬滴眼液在白内障术后炎症反应控制中的应用价值分析[J].首都食品与医药,2016(12):46-47.

相似文献/References:

[1]王 伟.普拉洛芬联合玻璃酸钠治疗眼科术后 干眼症的疗效观察[J].医学信息,2018,(12):139.[doi:10.3969/j.issn.1006-1959.2018.12.043]
 WANG Wei.Clinical Efficacy of Pranoprofen and Sodium Hyaluronate in the Treatment of Xerophthalmia after Ophthalmology[J].Medical Information,2018,(04):139.[doi:10.3969/j.issn.1006-1959.2018.12.043]
[2]饶丽娜.三种手术方式在合并白内障的原发性急性闭角型青光眼中的疗效对比[J].医学信息,2018,(22):110.[doi:10.3969/j.issn.1006-1959.2018.22.030]
 RAO Li-na.Comparison of the Effect of Three Surgical Methods in the Treatment of Primary Angle Closure Glaucoma with Cataract[J].Medical Information,2018,(04):110.[doi:10.3969/j.issn.1006-1959.2018.22.030]
[3]杨秋艳.羧甲基纤维素钠眼液治疗糖尿病合并白内障术后干眼的效果评价[J].医学信息,2018,(23):142.[doi:10.3969/j.issn.1006-1959.2018.23.041]
 YANG Qiu-yan.Evaluation of the Effect of Carboxymethylcellulose Sodium Eye Solution on Postoperative Dry Eyes in Diabetic Patients Combined with Cataract[J].Medical Information,2018,(04):142.[doi:10.3969/j.issn.1006-1959.2018.23.041]
[4]闫爱民,陈凤华.双眼植入衍射型多焦点人工晶体与单眼植入术后视觉质量对比[J].医学信息,2019,(05):103.[doi:10.3969/j.issn.1006-1959.2019.05.031]
 YAN Ai-min,CHEN Feng-hua.Comparison of Visual Quality after Binocular Implantation of Diffractive Multifocal Intraocular Lens and Monocular Implantation[J].Medical Information,2019,(04):103.[doi:10.3969/j.issn.1006-1959.2019.05.031]

更新日期/Last Update: 2019-03-07